HemoSonics, LLC is breaking new ground in point-of-care Viscoelastic #hemostasis testing. When time is critical, the Quantra® QPlus® System offers rapid, accurate, and easy to understand results that enable clinicians to make more informed #transfusion decisions, more quickly. This novel, cartridge-based POC VET system now has De Novo marketing authorization in the USA and is intended to assess the coagulation status of perioperative patients at the point of care.

Information Technology

HemoSonics

HemoSonics' headquarters in Charlottesville, VA, United States

Robert A. Roda

Steve Erwine

Raymond Szafranski Jr.

Joseph A. Steele

Deborah O. Sinclair

Deborah Winegar

Raymond L Szafranski Jr

Francesco Viola

Joe Steele

The Clinical and Medical Team at HemoSonics is responsible for overseeing the clinical application of the Quantra® QPlus® System, ensuring its integration into medical practices, and providing education and support to clinicians. This team works closely with healthcare professionals to facilitate informed transfusion decisions, conducts clinical research, and drives the adoption of the system through sales and regional management efforts.

Clinical and Medical Team

The Engineering Team at HemoSonics is responsible for the development, testing, and quality assurance of the Quantra® QPlus® System. This multidisciplinary team works collaboratively to design, implement, and optimize both the software and hardware components of the system, ensuring compliance with regulatory standards and enhancing the overall user experience. They focus on innovation and continuous improvement to support critical, data-driven clinical decisions in real-time.

Engineering Team

The Scientific and Development Team at HemoSonics is responsible for the research, development, optimization, and support of the company's innovative point-of-care viscoelastic hemostasis testing systems. This multidisciplinary team works collaboratively to develop assays, support technical operations, conduct clinical research, and manage reagent manufacturing, ensuring the delivery of rapid, accurate, and reliable coagulation status assessments to clinicians.

Scientific and Development Team

The Sales and Marketing Team at HemoSonics is responsible for driving the adoption and usage of the Quantra® QPlus® System. They engage with healthcare professionals to promote the system's benefits, develop strategic marketing campaigns, and manage regional sales efforts to expand the company's market presence in point-of-care hemostasis testing.

Sales and Marketing Team

The Finance & Accounting team at HemoSonics oversees financial planning, reporting, and compliance to ensure the company's fiscal health and regulatory adherence. This team manages budgeting, cost analysis, and financial transactions to support the innovative development and deployment of the Quantra® QPlus® System, aiding in precise and timely coagulation status assessments.

Finance & Accounting

The Leadership Team at HemoSonics drives the strategic vision and operational goals of the company, focusing on advancing point-of-care hemostasis testing. This team, composed of key executives including the CEO, CFO, and VPs of Clinical Affairs and Research & Development, works collaboratively to ensure the successful development and commercialization of innovative products like the Quantra® QPlus® System, ultimately enhancing clinical decision-making and patient outcomes in perioperative settings.

HemoSonics

Org chart

Teams

Clinical and Medical Team

Engineering Team

Scientific and Development Team

Sales and Marketing Team

Finance & Accounting

Leadership Team

Offices

HemoSonics

Org chart

Teams

Clinical and Medical Team

Engineering Team

Scientific and Development Team

Sales and Marketing Team

Finance & Accounting

Leadership Team

Offices

Related companies